A growing number of studies suggested that adiponectin is decreased in obesity and negatively correlated to visceral fat mass, inflammation, heart disease, injury, and many other diseases but positively to insulin sensitivity and promotes weight loss [30–33]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.